Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Diagnostics | Free Full-Text | Anti-Protein-Arginine Deiminase 4 IgG and IgA Delineate Severe Rheumatoid Arthritis
JCM | Free Full-Text | Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with
PE Goat F(ab')2 Anti-Human IgA | SouthernBiotech
Frontiers | Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
IgA from human serum reagent grade, ≥95% (HPLC), buffered aqueous solution | Sigma-Aldrich
Multiple Myeloma | SpringerLink
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
The "four hit" hypothesis of IgA nephropathy. Hit 1: Appearance in... | Download Scientific Diagram
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses - Mucosal Immunology
Multiple myeloma with t(11;14): impact of novel agents on outcome | Blood Cancer Journal
IgA nephropathy | Cleveland Clinic Journal of Medicine
IGA-2, Tina-quant IgA Gen.2
t(4;14)(p16;q32) IGH/FGFR3 and WHSC1
Frontiers | Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report | Journal of Medical Case Reports
The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts - ScienceDirect
Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
Multiple myeloma with t(11;14): impact of novel agents on outcome | Blood Cancer Journal
Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
Frontiers | Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
IJMS | Free Full-Text | Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers - ScienceDirect
